ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 639505 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 639505; 2) Community: the network communities that were significantly associated with the response to NSC 639505; 3) Molecule: the relationships between components within communities and NSC 639505; 4) MDR: the compounds that were significantly associated with the NSC 639505.

NSC Compound Enrichment Correlation
NSC 302991 Camptothecin Derivative 0.0385203205529754 0.21900841
NSC 364830 Camptothecin Derivative 0.0385203205529754 0.072777026
NSC 382050 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)- 6-ethyl-, monoethanesulfonate 0.0385203205529754 0.19031719
NSC 624172 Null 0.0385203205529754 0.59671288
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.0385203205529754 0.35730047
NSC 636092 Pyridine-3,5-dicarboxamide, 1,4-dihydro-2,6-dimethyl- 4-[4-(dimethylamino)phenyl]-N,N'-diphenyl- 0.0385203205529754 0.10690738
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.0385203205529754 0.49454603
NSC 645317 Sanguilutine pseudobase 0.0385203205529756 0.33840285
NSC 657822 (1R)-3,3-Dibromocamphor 0.0385203205529756 0.47612059
NSC 661415 2-Chloro-3-(2-butoxyethoxy)naphthazarin 0.0385203205529756 0.54501916
Total:91  Current:72    [First] [Prev] [Next] [Last]